Where France covers prescribed tests after suspected spiking
France’s three-year pilot covers prescribed analyses after suspected substance-facilitated assault, including before a police complaint. It operates in Hauts-de-France, Île-de-France, Pays de la Loire and Guadeloupe.
Last checked
Guadeloupe joined on 1 September 2026. Article 222-30-1 concerns secretly administering a substance to impair discernment or control with the aim of committing rape or sexual assault. Separately, a bill before the Senate would clarify that voluntary consumption alone cannot establish consent to a sexual act.